Clinical utility of trifluoperazine in the treatment of obsessive-compulsive disorder: A case report.

Chithra, Nellai K; Suhas, Satish; Sreeraj, Vanteemar S; Venkatasubramanian, Ganesan

Chithra, Nellai K; Suhas, Satish; Sreeraj, Vanteemar S; Venkatasubramanian, Ganesan.

Afiliação

Chithra NK; Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), India. Electronic address: chithra.arulmathy@gmail.com.
Suhas S; Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), India.
Sreeraj VS; Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), India.
Venkatasubramanian G; Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), India.

Asian J Psychiatr ; 71: 103051, 2022 05.

Article em En | MEDLINE | ID: mdl-35245723

Assuntos

Transtorno Obsessivo-Compulsivo; Trifluoperazina; Humanos; Transtorno Obsessivo-Compulsivo/tratamento farmacológico; Risperidona/uso terapêutico; Inibidores Seletivos de Recaptação de Serotonina/uso terapêutico; Trifluoperazina/farmacologia; Trifluoperazina/uso terapêutico

Palavras-chave

Augmentation; OCD; Trifluoperazine; Typical antipsychotic

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trifluoperazina / Transtorno Obsessivo-Compulsivo Limite: Humans Idioma: En Revista: Asian J Psychiatr Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google